missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Human HGFR/c-MET Antibody, R&D Systems™

Mouse Monoclonal Antibody
Marque: R&D Systems MAB3581-100
Les retours ne sont pas autorisés pour ce produit.
Afficher la politique du retour.
Description
HGFR/c-MET Monoclonal specifically detects HGFR/c-MET in Human samples. It is validated for Immunohistochemistry, Immunocytochemistry, ELISA Capture (Matched Antibody Pair).
Spécification
| HGFR/c-MET | |
| Monoclonal | |
| Unconjugated | |
| Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative | |
| AUTS9, c-Met, cMET, EC 2.7.10, EC 2.7.10.1, hepatocyte growth factor receptor, HGF R, HGF receptor, HGF/SF receptor, HGFR, MET, Met (c-Met), met proto-oncogene (hepatocyte growth factor receptor), met proto-oncogene tyrosine kinase, oncogene MET, Proto-oncogene c-Met, RCCP2, Scatter factor receptor, SF receptor, Tyrosine-protein kinase Met | |
| Mouse | |
| Protein A or G purified from hybridoma culture supernatant | |
| RUO | |
| 4233 | |
| Reconstitute at 0.5 mg/mL in sterile PBS. | |
| Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. | |
| IgG1 |
| ELISA | |
| 85503 | |
| ELISA Capture (Matched Antibody Pair) 2-8 ug/mL | |
| P08581 | |
| MET | |
| Mouse myeloma cell line NS0-derived recombinant human HGF R/c-MET Glu25-Thr932 Accession # P08581 | |
| 100 μg | |
| Primary | |
| Detects human HGF R/c-MET in ELISAs. In sandwich immunoassays, no cross-reactivity with recombinant human (rh) EGFR or rhIGF-1 R is observed. | |
| Human | |
| Supernatant |
Correction du contenu d'un produit
Veuillez fournir vos retours sur le contenu du produit en remplissant le formulaire ci-dessous.
Nom du produit
For Research Use Only
Vous avez repéré une opportunité d'amélioration ?Partager une correction de contenu